Methylprednisolone Treatment of Friedreich Ataxia

Summary

This study will explore whether methylprednisolone treatment is safe, well-tolerated, and beneficial in patients that are diagnosed with Friedreich Ataxia (FRDA). The study will also explore if methylprednisolone has any effects on biomarkers associated with FRDA. All subjects in the study will receive the same steroid treatment.

Timeline

Start

2015-06

Primary completion

2017-12

Completion

2018-04

Drugs

Indications